Cohen Klingenstein LLC Buys Shares of 10,000 Marsh & McLennan Companies, Inc. $MRSH

Cohen Klingenstein LLC purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 10,000 shares of the financial services provider’s stock, valued at approximately $1,734,000.

Other hedge funds have also made changes to their positions in the company. Solstein Capital LLC bought a new stake in Marsh & McLennan Companies during the fourth quarter worth approximately $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth $27,000. Golden State Wealth Management LLC acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at $27,000. Finally, Atlas Capital Advisors Inc. acquired a new position in Marsh & McLennan Companies during the fourth quarter worth about $28,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on MRSH shares. Wells Fargo & Company cut their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price on the stock in a report on Wednesday, May 6th. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Keefe, Bruyette & Woods lifted their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research report on Friday, April 17th. Finally, Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and a consensus target price of $200.19.

Marsh & McLennan Companies Stock Performance

MRSH opened at $161.96 on Friday. The firm has a market capitalization of $78.24 billion, a PE ratio of 20.25, a price-to-earnings-growth ratio of 2.37 and a beta of 0.62. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $220.32.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.Marsh & McLennan Companies’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.